PERIOPERATIVE BLOOD TRANSFUSION AND GASTRIC CANCER: ADVERSE EFFECTS OR UNFAVOURABLE CONDITIONS OF PRETREATMENT?

1990 ◽  
Vol 60 (10) ◽  
pp. 765-772 ◽  
Author(s):  
Koji Yamaguchi ◽  
Noritaka Tokui ◽  
Shogo Maeda ◽  
Tatsuya Kominami ◽  
Kazuhiko Nakamura ◽  
...  
2021 ◽  
Vol 149 ◽  
pp. 73-79
Author(s):  
James J. Zhou ◽  
Courtney Hemphill ◽  
Corey T. Walker ◽  
S. Harrison Farber ◽  
Juan S. Uribe

2020 ◽  
Author(s):  
Haoquan Huang ◽  
Zhixiao Han ◽  
Xia Liang ◽  
Zhongqi Liu ◽  
Shi Cheng ◽  
...  

Abstract Background This study aimed to construct and validate a nomogram composed of preoperative variables to predict perioperative blood transfusion for gastric cancer surgery. Methods 600 gastric cancer patients undergoing gastrectomy between January 2010 and December 2015 were selected as primary cohort. 399 patients from January 2016 to June 2019 were collected as validation cohort. In the primary cohort, univariate and multivariate analyses were performed to identify independent risk factors for blood transfusion. Using Akaike information criterion, selected variables were incorporated to construct a nomogram. Validations of the nomogram were performed in the primary and validation cohort. Discrimination of the nomogram was assessed by the concordance index (C-index) and calibration of the nomogram was assessed by calibration curve and Hosmer–Lemeshow goodness-of-fit test. Results The following independent risk factors for transfusion were identified: Charlson comorbidity index score over 3 (odds ratio (OR) 2.15), tumor location (diffuse vs upper: OR 1.50), pTNM stage (III vs I: OR 3.17), type of gastrectomy (subtotal vs total gastrectomy: OR 0.58), extragastric organ resection (OR 2.03) and preoperative hemoglobin less than 80 g/l (vs over 120 g/l: OR 66.03). C-index was 0.863 and 0.901 in the primary and validation cohort, respectively, indicating good discrimination of the nomogram. Both calibration curves and Hosmer–Lemeshow goodness-of-fit tests (P-value 0.716 and 0.935) demonstrated high agreement between prediction and actual outcome. Conclusion A nomogram composed of preoperative variables to predict blood transfusion for gastric cancer surgery was developed and validated. This nomogram could be used to improve utilization of packed red blood cells.


Cancer ◽  
1990 ◽  
Vol 66 (11) ◽  
pp. 2331-2335 ◽  
Author(s):  
Sunao Moriguchi ◽  
Yoshihiko Maehara ◽  
Kouhei Akazawa ◽  
Keizo Sugimachi ◽  
Yoshiaki Nose

2014 ◽  
Vol 32 (3_suppl) ◽  
pp. 100-100
Author(s):  
Malcolm Hart Squires ◽  
David A. Kooby ◽  
George A. Poultsides ◽  
Sharon M. Weber ◽  
Mark Bloomston ◽  
...  

100 Background: Whether perioperative blood transfusion has a negative prognostic effect on recurrence and survival in patients undergoing resection of gastric adenocarcinoma (GAC) is unknown. Methods: All patients who underwent resection for GAC from 2000-2012 at 7 institutions were identified. The effect of transfusion on recurrence-free (RFS) and overall survival (OS) in the context of adverse clinicopathologic variables was examined by univariate (UV) and multivariate (MV) regression analyses. Results: Out of 965 pts, 765 underwent curative intent, R0 resection. Median FU for survivors was 44 mos; 30-day deaths were excluded. Median estimated blood loss (EBL) was 250cc and 166 pts (22%) received perioperative RBC transfusions. 5-yr RFS was 51% in transfused and 61% in non-transfused patients (p=0.01). Median OS was decreased in patients receiving transfusions (19 vs 50 mos, p<0.001). On MV analysis, transfusion remained an independent risk factor for decreased RFS (HR 2.8; 95% CI: 1.2-6.5; p=0.01) and decreased OS (Table), regardless of EBL or need for splenectomy. Timing (intraop vs postop) and volume (# of units) did not alter the effect of transfusion on survival. Non-transfused pts were more likely to receive adjuvant therapy (56% vs 44%; p=0.01). Conclusions: Perioperative blood transfusion is associated with decreased recurrence-free and overall survival following resection of gastric cancer, independent of adverse clinicopathologic factors. This supports the judicious use of perioperative transfusion during resection of gastric cancer. [Table: see text]


2000 ◽  
Vol 33 (1) ◽  
pp. 1-5
Author(s):  
Tsuneaki Fujiya ◽  
Hideaki Yamanami ◽  
Junichi Mikuni ◽  
Yoichiro Kakugawa ◽  
Yasuhiko Kamiyama ◽  
...  

2000 ◽  
Vol 3 (1) ◽  
pp. 24-27 ◽  
Author(s):  
Nobuo Murata ◽  
Yasuo Idezuki ◽  
Toshiro Konishi ◽  
Hiromu Watanabe ◽  
Yoshio Ushirokoji ◽  
...  

2019 ◽  
Vol 45 (2) ◽  
pp. e77
Author(s):  
C. Henriques ◽  
H. Santos-Sousa ◽  
J. Nogueiro ◽  
J. Barbosa ◽  
J. Costa-Maia

Sign in / Sign up

Export Citation Format

Share Document